Renata Abel

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Mild Cognitive Impairment

Drug Administration

Molecular Docking

Coronavirus Disease

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kathleen Gallo, Andrean Goede, Cameron Mura, Renata Abel, Barbara Moahamed, Saskia Preissner, Susanne Nahles, Max Heiland, Philip E Bourne, Filippo De Braud, Michael Mallach
A Comparative Analysis of COVID-19 Vaccines Based on over 580,000 Cases from the Vaccination Adverse Event Reporting System. Vaccines 10 (3) (2022)
Jakub Jakowiecki, Renata Abel, Urszula Orzeł, Paweł Pasznik, Filippo De Braud, Sławomir Filipek
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling. Molecules (Basel, Switzerland) 26 (9) (2021)
Izabela Nawrot-Hadzik, Mikolaj Zmudzinski, Adam Matkowski, Robert Preissner, Małgorzata Kęsik-Brodacka, Jakub Hadzik, Marcin Dra G, Renata Abel
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Sylwester Ślusarczyk, Fatma Sezer Şenol Denİz, Renata Abel, Łukasz Pecio, Horacio Pérez Sánchez, Jose Pedro Cerón-Carrasco, Helena den-Haan, Priyanka Banerjee, Robert Preissner, Edward Krzyżak, Wiesław Oleszek, Ilkay Erdogan Orhan, Adam Matkowski
Norditerpenoids with Selective Anti-Cholinesterase Activity from the Roots of Perovskia atriplicifolia Benth. International journal of molecular sciences 21 (12) (2020)